Dry Eye Syndrome Clinical Trial
Official title:
Dry Eye Syndrome Description During Cataract Surgery, With Multimodal Analysis of the Ocular Surface
The main objective is to describe the characteristics of dry eye syndrome before and after
surgery at one month of cataract surgery, using a multimodal analysis of the ocular surface.
The secondary objectives are to evaluate:
- Predictive factors of dry eye syndrome during cataract surgery:
- The characteristics of dry eye syndrome
- Implications for the patient's quality of life
Type of study: Descriptive study, interventional research involving the human person at risk
and with minimal constraints (type 2), prospective, with longitudinal cohort follow-up,
mono-centric.
Number of centres: 1; The protocol will take place in the ophthalmology department of the
Clermont-Ferrand University Hospital.
Study description: The study will follow the normal protocol for cataract surgery. Patients
will not have any additional consultation to perform this study. The classic consultation
scheme involves a preoperative appointment to set the surgical indication and inform patients
about the procedure, the benefits - risks and usual follow-up.. During this consultation, the
patient will have to complete a quality of life questionnaire in addition to the standard
protocol, and will also have to perform a non-invasive Schirmer test and a non-contact
examination of the ocular surface analysis (Lacrydiag from the Quantel laboratory, with CE
marking). The patient will be seen again in a traditional post-operative consultation one
month after the surgery, the same examinations will be performed.
We will use the pre and postoperative ophthalmological consultation reports, the operative
report, as well as a patient questionnaire and surface analysis examination reports to
conduct the study.
Main judgment criteria:
Analysis of the ocular surface defined by the study:
- OSDI questionnaire score (Ocular Surface Disease Index)
- Corneal / conjunctival states visible in slit lamp (Oxford score)
- Eyelid analysis by meibography (qualitative analysis of the eyelid glands of Meibomius
and calculation of the percentage loss)
- Study of the tear film:
Lipid layer by interferometry (thickness assessment; qualitative and quantitative analysis)
Aqueous layer by measuring the height of the lacrimal meniscus (quantitative analysis)
Mucinic layer by evaluating the stability of the tear film (Non Invasive Break Up Time)
o Evaluation of tear secretion (Schirmer type I test)
- Eyelid analysis and tear film study will be performed simultaneously by the non-invasive
test Lacrydiag.
- Definition and classification of an SSO according to different severity grades.
Secondary Judgement Criteria: Evaluate during cataract surgery:
- Predictive factors of dry eye syndrome during cataract surgery:
- Age
- Gender
- General history / Systemic diseases / Eye diseases o General and topical medication
use
- Type of anesthesia used for surgery
- The characteristics of dry eye syndrome
- Incidence of dry eye syndrome before and after surgery in our centre
- Correlation between subjective criteria (OSDI score) and objective criteria
(results of evaluation by non-invasive tests)
- Comparison on a sample of patients (without adelphic eye pathology) in after
cataract surgery between the two eyes.
- Consequences on the patient's quality of life (translated questionnaire from the Ocular
Surface Disease Index from 0 to 48)
- visual symptoms
- activity limitations
- adaptation to the environment
- Post-operative satisfaction
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02597803 -
Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-1
|
Phase 2/Phase 3 | |
Completed |
NCT02522312 -
A Retrospective Analysis of Restasis® Benefits in Dry Eye Contact Lens Patients
|
N/A | |
Completed |
NCT01863368 -
Clinical Evaluation of Systane® ULTRA Compared to OPTIVE® in Ocular Surface Staining
|
N/A | |
Completed |
NCT01753752 -
Evaluation of the Corneal Residence Time of Chitosan-N-acetylcysteine Eye Drops in Patients With Dry Eye Syndrome After Single and Multiple Instillation
|
Phase 2 | |
Completed |
NCT01753687 -
Correlation of Different Signs for Assessment of Dry Eye Syndrome
|
N/A | |
Completed |
NCT01212471 -
A Dose Ranging Study to Evaluate Safety and Efficacy of Bromfenac Ophthalmic Solution in Dry Eye Disease
|
Phase 3 | |
Completed |
NCT01198782 -
Evaluating Safety and Efficacy of FID 112903 Post Discontinuation of Long-term Use of RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05%
|
Phase 4 | |
Completed |
NCT01162954 -
Phase I Study to Evaluate the Tolerability of Eye Drop DA-6034 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00535054 -
Study to Assess the Safety and Patients' Satisfaction of Tears Again* in the Treatment of Dry Eye Symptoms
|
N/A | |
Completed |
NCT00544713 -
Evaluate the Safety and Efficacy of a New Artificial Tear for Use After LASIK Surgery
|
N/A | |
Completed |
NCT00344721 -
A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome
|
N/A | |
Completed |
NCT03830359 -
Efficacy, Safety of T2769 in Dry Eye Disease
|
N/A | |
Completed |
NCT04139122 -
Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease
|
Phase 1/Phase 2 | |
Completed |
NCT02758327 -
Evaluation of Tear Osmolarity Over Time With Sustained Use of Thera Tears Lubricating Drops
|
Phase 4 | |
Completed |
NCT02066051 -
IPL and Meibomian Gland Expression to Treat Ocular Rosacea Ocular GVHD
|
N/A | |
Completed |
NCT01970917 -
Effect of Olixia Pure® Eye Drops on Tear Film Thickness in Healthy Subjects
|
Phase 4 | |
Completed |
NCT02092207 -
Phase 2 Study to Evaluation the Safety and Efficacy of Orally Administered KL7016 in Patients With Dry Eye Syndrome
|
Phase 2 | |
Completed |
NCT01541891 -
Efficacy and Safety of PRO-148 Ophthalmic Solution Versus SYSTANE® in the Treatment of Patients With Dry Eye Syndrome
|
Phase 2 | |
Completed |
NCT01252121 -
Residence Time Evaluation of Systane Ultra Lubricant Eye Drops vs. Hialid and Saline
|
N/A | |
Completed |
NCT00765804 -
Safety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Dry Eye
|
Phase 2 |